Insulet : PODD

All Insulet Articles

27 Articles

Chris Lange | Feb 22, 2018 at 4:13 PM EST

8 Stocks Getting Multiple Analyst Upgrades and Downgrades After Earnings and News

24/7 Wall St. has included a montage of companies that are seeing multiple upgrades and downgrades on the analyst front…

Jon C. Ogg | Nov 3, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter, YogaWorks and More

The top analyst upgrades, downgrades and other research calls from Friday include Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter…

Lee Jackson | Feb 28, 2017 at 9:30 AM EST

Top Analyst Upgrades and Downgrades: Apple, CVS Health, Priceline, Teva Pharmaceuticals, Workday and Many More

Tuesday’s top analyst upgrades, downgrades and initiations include Apple, CVS Health, Priceline, Teva Pharmaceutical and Workday.

Lee Jackson | Jun 23, 2016 at 10:55 AM EDT

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to…

Jon C. Ogg | Jun 9, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Apple, Dollar General, Noble Energy, Oracle and More

Tuesday's top analyst upgrades, downgrades and initiations include AMD, Apple, Dollar General, Noble Energy and Oracle.

Jon C. Ogg | Feb 27, 2015 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: BofA, CA, CBOE, CSX, FedEx, ITT, Potbelly and More

Friday's top analyst upgrades, downgrades and initiations include Bank of America, CA, CBOE, CSX, FedEx, ITT and Potbelly.

Jon C. Ogg | Feb 18, 2015 at 8:35 AM EST

Top Analyst Upgrades and Downgrades: Amarin, CenturyLink, Legg Mason, Rackspace, Transocean, Valero and More

Wednesday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Amarin, CenturyLink, Legg Mason, Rackspace, Transocean and Valero…

Lee Jackson | Dec 9, 2014 at 9:55 AM EST

3 Medical Device Stocks to Buy as Obesity and Diabetes Epidemic Spreads

Cowen analysts point out that an estimated 300 million people have diabetes globally, and that number is expected to skyrocket…

Jon C. Ogg | Mar 21, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, March 21, 2014.…

Jon C. Ogg | May 8, 2013 at 8:40 AM EDT

Top Analyst Downgrades and Stocks to Sell: CA Technologies, Comerica, ValueClick and More

Jon OggInvestors frequently get to see the analyst upgrades and Buy ratings from Wall Street, but they often do not…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Aug 13, 2008 at 6:32 AM EDT

24/7 Wall St. Most Overpaid CEO Of The Day: Insulet Corp (PODD) CEO Duane DeSisto

Insulet (PODD) reported earnings well below Wall St. expectations and revised its forecast for the rest of the year down.…

1 2

Insulet : PODD

All Insulet Articles

8 Stocks Getting Multiple Analyst Upgrades and Downgrades After Earnings and News

Top Analyst Upgrades and Downgrades: Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter, YogaWorks and More

Top Analyst Upgrades and Downgrades: Apple, CVS Health, Priceline, Teva Pharmaceuticals, Workday and Many More

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Top Analyst Upgrades and Downgrades: AMD, Apple, Dollar General, Noble Energy, Oracle and More

Top Analyst Upgrades and Downgrades: BofA, CA, CBOE, CSX, FedEx, ITT, Potbelly and More

Top Analyst Upgrades and Downgrades: Amarin, CenturyLink, Legg Mason, Rackspace, Transocean, Valero and More

3 Medical Device Stocks to Buy as Obesity and Diabetes Epidemic Spreads

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

Top Analyst Downgrades and Stocks to Sell: CA Technologies, Comerica, ValueClick and More

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

24/7 Wall St. Most Overpaid CEO Of The Day: Insulet Corp (PODD) CEO Duane DeSisto

USO Up 65% This Year, Down 77% From What It Should Be

VOO’s 0.03% Fee Hides a Costlier Truth About Taxes and Concentration

ARKK’s 0.75% Fee Quietly Costs You $55 a Year on Every $10,000 Invested

New Retirees Can Save up to $6,936 in Medicare Premiums by Filing a Single Form - But You Only Get 60 Days

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

USO Up 65% This Year, Down 77% From What It Should Be

VOO’s 0.03% Fee Hides a Costlier Truth About Taxes and Concentration

Insulet : PODD

All Insulet Articles

8 Stocks Getting Multiple Analyst Upgrades and Downgrades After Earnings and News

Top Analyst Upgrades and Downgrades: Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter, YogaWorks and More

Top Analyst Upgrades and Downgrades: Apple, CVS Health, Priceline, Teva Pharmaceuticals, Workday and Many More

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Top Analyst Upgrades and Downgrades: AMD, Apple, Dollar General, Noble Energy, Oracle and More

Top Analyst Upgrades and Downgrades: BofA, CA, CBOE, CSX, FedEx, ITT, Potbelly and More

Top Analyst Upgrades and Downgrades: Amarin, CenturyLink, Legg Mason, Rackspace, Transocean, Valero and More

3 Medical Device Stocks to Buy as Obesity and Diabetes Epidemic Spreads

Top Analyst Upgrades and Downgrades: Apple, Boeing, Exelon, Herbalife, Symantec and More

Top Analyst Downgrades and Stocks to Sell: CA Technologies, Comerica, ValueClick and More

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

24/7 Wall St. Most Overpaid CEO Of The Day: Insulet Corp (PODD) CEO Duane DeSisto

USO Up 65% This Year, Down 77% From What It Should Be

VOO’s 0.03% Fee Hides a Costlier Truth About Taxes and Concentration

ARKK’s 0.75% Fee Quietly Costs You $55 a Year on Every $10,000 Invested

Featured Reads

New Retirees Can Save up to $6,936 in Medicare Premiums by Filing a Single Form - But You Only Get 60 Days

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice